ID

26224

Beskrivning

Study ID: 101468/125 Clinical Study ID: SKF-101468/125 Study Title: A double-blind, multicentre, flexible dose, L-dopa controlled study of ropinirole to investigate A) neuroprotective effect as measured by 3D PET scanning, and B) ophthalmological safety, in patients with early Parkinson’s disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome

Nyckelord

Versioner (1)
  1. 2017-10-12 2017-10-12 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

12 oktober 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Concomitant Medication/Adverse Experiences

Engelsk

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Concomitant Medication/Adverse Experiences

1 Formulär  
Concomitant Medication Information
Beskrivning

Concomitant Medication Information

Concomitant Medication Information noticed
Beskrivning

Concomitant Medication Information

Datatyp

boolean

Concomitant Medication
Beskrivning

Concomitant Medication

Drug Name (Trade Name Preferred)
Beskrivning

Drug Name (Trade Name Preferred)

Datatyp

text

Total daily dose (e.g. 500 mg)
Beskrivning

Total daily dose

Datatyp

integer

Måttenheter
  • mg
mg
Medical Condition
Beskrivning

Medical Condition

Datatyp

text

Approximate Start Date
Beskrivning

Approximate Start Date

Datatyp

date

End Date (leave blank if continuing)
Beskrivning

End Date

Datatyp

date

Continuing
Beskrivning

Continuing

Datatyp

boolean

For SB
Beskrivning

For SB

Datatyp

text

Adverse Experiences
Beskrivning

Adverse Experiences

Definition of serious adverse experiences
Beskrivning

A serious adverse experience is any experience which is -fatal -life threatening - disabling - incapacitating - results in hospitalization - prolongs a hospital stay - associated with congenital abnormality, carcinoma or overdose

Datatyp

boolean

Adverse Experience Details
Beskrivning

Adverse Experience Details

Experience
Beskrivning

Experience

Datatyp

text

For SB
Beskrivning

For SB

Datatyp

text

Date Started
Beskrivning

Date Started

Datatyp

date

Date Stopped
Beskrivning

Date Stopped

Datatyp

date

Duration (if less than 24hrs)
Beskrivning

Duration

Datatyp

float

Måttenheter
  • hrs
hrs
Experience continuing
Beskrivning

Experience continuing

Datatyp

boolean

Course: Continuous
Beskrivning

Course

Datatyp

boolean

If No, no. of episodes
Beskrivning

No. of episodes

Datatyp

integer

Intensity
Beskrivning

Intensity

Datatyp

text

Action taken on Study Medication
Beskrivning

Action taken on Study Medication

Datatyp

integer

Suspected Relationship
Beskrivning

Suspected Relationship

Datatyp

text

Corrective Therapy
Beskrivning

Corrective Therapy

Datatyp

text

Do you consider this a serious adverse experience by the definitions on the tab?
Beskrivning

If patient died complete Form D

Datatyp

integer

Investigator´s Signature
Beskrivning

Investigator´s Signature

Investigator´s Signature
Beskrivning

Investigator´s Signature

Datatyp

text

Date
Beskrivning

Date

Datatyp

date

Tillbaka till toppen

Similar models

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Concomitant Medication/Adverse Experiences

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Concomitant Medication Information
Concomitant Medication Information
Item
Concomitant Medication Information noticed
boolean
Item Group
Concomitant Medication
Drug Name (Trade Name Preferred)
Item
Drug Name (Trade Name Preferred)
text
Total daily dose
Item
Total daily dose (e.g. 500 mg)
integer
Medical Condition
Item
Medical Condition
text
Approximate Start Date
Item
Approximate Start Date
date
End Date
Item
End Date (leave blank if continuing)
date
Continuing
Item
Continuing
boolean
For SB
Item
For SB
text
Item Group
Adverse Experiences
Definition of serious adverse experiences
Item
Definition of serious adverse experiences
boolean
Item Group
Adverse Experience Details
Experience
Item
Experience
text
For SB
Item
For SB
text
Date Started
Item
Date Started
date
Date Stopped
Item
Date Stopped
date
Duration
Item
Duration (if less than 24hrs)
float
Experience continuing
Item
Experience continuing
boolean
Course
Item
Course: Continuous
boolean
No. of episodes
Item
If No, no. of episodes
integer
Item
Intensity
text
Intensity
Code List
Intensity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Item
Action taken on Study Medication
integer
Action taken on Study Medication
Code List
Action taken on Study Medication
CL Item
None (1)
CL Item
Dose decreased  (2)
CL Item
Dose increased (3)
CL Item
Drug stopped (4)
CL Item
Dose interrupted (5)
Item
Suspected Relationship
text
Suspected Relationship
Code List
Suspected Relationship
CL Item
Related (1)
CL Item
Possibly related (2)
CL Item
Probably unrelated  (3)
CL Item
Unrelated (4)
Item
Corrective Therapy
text
Corrective Therapy
Code List
Corrective Therapy
CL Item
Yes (If "Yes" record on Medication form) (1)
CL Item
No (2)
Item
Do you consider this a serious adverse experience by the definitions on the tab?
integer
Serious Adverse Experience by Definition
Code List
Do you consider this a serious adverse experience by the definitions on the tab?
CL Item
Yes (If "Yes", report to SB by telephone within 24 hours) (1)
CL Item
No (2)
Item Group
Investigator´s Signature
Investigator´s Signature
Item
Investigator´s Signature
text
Date
Item
Date
date
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial